ClinicalTrials.gov record
Completed Phase 3 Interventional

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer

ClinicalTrials.gov ID: NCT01360853

Public ClinicalTrials.gov record NCT01360853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer

Study identification

NCT ID
NCT01360853
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Traws Pharma, Inc.
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • Gemcitabine Drug
  • ON 01910.Na Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
May 31, 2015
Completion
Nov 30, 2015
Last update posted
Aug 3, 2016

2011 – 2015

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
UCSD Moores Cancer Center La Jolla California 92037
Desert Comprehensive Cancer Center Palm Springs California 92262
Pacific Cancer Care Salinas California 93901
Premiere Oncology Santa Monica California 90404
University of Colorado Cancer Center Aurora Colorado 80045
Kaiser Permanente Colorado Denver Colorado 80205
Poudre Valley Cancer Center of the Rockies Fort Collins Colorado 80528
Yale Cancer Center New Haven Connecticut 06519
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140
University of Hawaii Cancer Center Honolulu Hawaii 96813
University of Kansas Cancer Center Westwood Kansas 66205
UMASS Medical School Worcester Massachusetts 01655
Karmanos Cancer Institute Detroit Michigan 48201
Billings Clinic Cancer Center Billings Montana 59101
Roswell Park Cancer Institute Buffalo New York 14263
New York University Langone Medical Center New York New York 10016
University of Rochester Medical Center Rochester New York 14642
University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
Levine Cancer Institute Charlotte North Carolina 28204
Cone Health Cancer Center Greensboro North Carolina 27403
Hendersonville Hematology and Oncology at Pardee Hendersonville North Carolina 28971
Rex Cancer Center UNC Healthcare Raleigh North Carolina 27607
St. Alexis Medical Center-Mid Dakota Clinic PC Bismarck North Dakota 58501
University of Cincinnati Cancer Center Cincinnati Ohio 45219
Kaiser Permanente NW Portland Oregon 97227
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Medical University of South Carolina - Hollings Cancer Center Charleston South Carolina 29425
McLeod Regional Medical Center Florence South Carolina 29506
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232
Seattle Cancer Care Alliance Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01360853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2016 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01360853 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →